Back
Open Access

Cause of death and competing risk in patients with device-detected atrial fibrillation treated with apixaban or aspirin: Insights from the ARTESiA trial

Session: Stroke in atrial fibrillation (2)
Topic: Stroke in Atrial Fibrillation
Speaker: Doctor W. McIntyre (Hamilton, CA)
Event: EHRA 2026

Congress Presentation

Add to my library

Like

About the speaker

Doctor William McIntyre

Population Health Research Institute, Hamilton (Canada)
5 presentations
3 followers

5 more presentations in this session

Impact of coronary artery calcium score on the risk prediction for ischemic stroke in patients with atrial fibrillation

Speaker: Mr Y. Lee (Kwang Ju, KR)

Access
Abstract
Like
Thumbnail

Stroke risk stratification by coronary artery disease extent in patients with atrial fibrillation

Speaker: Associate Professor K. Lee (Gwangju, KR)

Access
Abstract
Like
Thumbnail

An increase in stroke risk factors over time without arrhythmia recurrence does not require restarting anticoagulation in low-risk atrial fibrillation patients after successful ablation. (RESTART-AF)

Speaker: Doctor A. Ballet (Antwerp, BE)

Access
Abstract
Like
Thumbnail

Incidence of left atrial thrombi in patients with atrial fibrillation and low thromboembolic risk: do we always need transesophageal echocardiography before rhythm control therapy?

Speaker: Mr S. Koenig (Leipzig, DE)

Access
Abstract
Like
Thumbnail

Loneliness as an independent predictor of long-term stroke risk in atrial fibrillation patients: a UK biobank cohort analysis

Speaker: Doctor B. Li (Xi'an, CN)

Access
Abstract
Like
Thumbnail

Access the full session

Stroke in atrial fibrillation (2)

Speakers: Doctor W. McIntyre, Mr Y. Lee, Associate Professor K. Lee, Doctor A. Ballet, Mr S. Koenig...
Access
Like
Thumbnail

About the event

Image

EHRA 2026

12 April - 14 April 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources
novartis Explore sponsored resources